The pharmacokinetics of Simplex-tobramycin bone cement

Journal of Bone and Joint Surgery - Series B

Volumn 85, Issue 5, 2003, Pages 646-649

  Sterling, G J ^a   Crawford, S ^a   Potter, J H ^a   Koerbin, G ^a   Crawford, R ^a  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BONE CEMENT; GENTAMICIN; PALACOS; TOBRAMYCIN SULFATE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG EXCRETION; DRUG SAFETY; DRUG URINE LEVEL; ELUTION; FEMALE; HIP OSTEOARTHRITIS; HUMAN; IMPLANTATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS INFECTION; TOTAL HIP PROSTHESIS; URINALYSIS;

EID: 0041669244     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620x.85b5.13746     Document Type: Article

References (13)

1. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Review of 10905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg [Br] 1997;79-B:590-5.
2. Malchau H, Herberts P. Prognosis of total hip replacement revision and rerevision rate in THR: a revision risk study of 149,359 primary operations. Scientific exhibition presented at the 65th annual meeting of the American Academy of Orthopaedic Surgeons, March 19-23, 1998, New Orleans, USA.
3. Trippel SB. Antibiotic-impregnated cement in total joint arthroplasty. J Bone Joint Surg [Am] 1986;68-A:1297-302.
4. Rosenthal AL, Rovell JM, Girard AE. Polyacrylic bone cement containing erythromycin and colistin I: in vitro bacteriological activity and diffusion properties of erythromycin, colistin and erythromycin/colistin combination. J Int Med Res 1976;4:296-304.
5. Scott CP, Higham PA, Dumbleton JH. Effectiveness of bone cement containing tobramycin: an in vitro susceptibility study of 99 organisms found in infected joint arthroplasty. J Bone Joint Surg [Br] 1999; 81-B:440-3.
6. Reynolds JE. Editor. Martindale. The extra Pharmacopoeia. Twenty-ninth ed. London: The Pharmaceutical Press, 1989:326-8.
7. Nelson CL, Griffin FM, Harrison BH, Cooper RE. In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop 1992;284:303-9.
8. Pritchett JW, Bortel DT. Tobramycin-impregnated cement in total hip replacements. Orthop Rev 1992;21:577-9.
9. Soto-Hall R, Saenz L, Tavernetti R, Cabaud HE, Cochran TP. Tobramycin in bone cement: an in-depth analysis of wound, serum and urine concentrations in patients undergoing total hip revision arthroplasty. Clin Orthop 1983;175:60-4.
10. Brien WW, Salvati EA, Klein R, Brause B, Stern S. Antibiotic impregnated bone cement in total hip arthroplasty: an in vivo comparison of the elution properties of tobramycin and vancomycin. Clin Orthop 1993;296:242-8.
11. Davies JP, Harris WH. Effect of hand mixing tobramycin on the fatigue strength of Simplex P. J Biomed Mater Res 1991;25:1409-14.
12. Klekamp J, Dawson JM, Haas DW, DeBoar D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999;14:339-46.
13. Nijhof MW, Dhert WJ, Tilman PB, Verbout AJ, Fleer A. Release of tobramycin from tobramycin-containing bone cement in bone and serum of rabbits. J Mats Sci: Mats in Med 1997;8:799-802.